title: Cut-off levels of CYFRA21-1 to differentiate between metastatic and non-metastatic NSCLC.
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Satoh
authors.forename: Hiroichi
authors.initials: H
authors.lastname: Ishikawa
authors.forename: Morio
authors.initials: M
authors.lastname: Ohtsuka
authors.forename: Kiyohisa
authors.initials: K
authors.lastname: Sekizawa
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000951:Antigens, Neoplasm / Q000097:blood*; D014408:Biomarkers, Tumor / Q000097:blood*; D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D053539:Keratin-19; D007633:Keratins; D008163:Luminescent Measurements; D008175:Lung Neoplasms / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D012016:Reference Values; D012680:Sensitivity and Specificity
chemical_list: D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D053539:Keratin-19; C102012:antigen CYFRA21.1; D007633:Keratins